Why is "Bumetanide" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-04-26 03:40:10
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Bumetanide entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-04-26 and was most recently seen on 2026-04-26.
Wikipedia Overview
Bumetanide, sold under the brand name Bumex among others, is a medication used to treat swelling and high blood pressure. This includes swelling as a result of heart failure, liver failure, or kidney problems. It may work for swelling when other medications have not. For high blood pressure it is not a preferred treatment. It is taken by mouth, or by injection into a vein or muscle. Effects generally begin within an hour and last for about six hours.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Treating autism with Bumetanide: Identification of responders using Q-Finder machine learning algorithm - Nature
-
FDA Approves Enbumyst, an Intranasal Formulation of Bumetanide - MPR - Medical Professionals Reference
-
FDA Approves Bumetanide Nasal Spray for Edema with Congestive Heart Failure - HCPLive
-
FDA Approves Bumetanide Nasal Spray for Edema With Heart Failure, Hepatic and Renal Disease - Pharmacy Times
-
Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray) - Yahoo Finance
-
Corstasis Therapeutics Announces FDA Approval of ENBUMYST™ (bumetanide nasal spray) for the Treatment of Edema Associated with Congestive Heart Failure, Liver Disease and Kidney Disease - Business Wire
-
Bumetanide shows promise for some children with autism, Swedish study finds - Göteborgs universitet
-
Shandong Xinhua Pharmaceutical Wins NMPA Approval for Bumetanide Injection - TipRanks
-
Approved "Water Pill" Bumetanide May Reduce Alzheimer’s Risk - Being Patient
-
FDA approves nasal spray for edema associated with congestive heart failure - Cardiovascular Business
-
Corstasis scores FDA nod for nasal spray treatment, touts sales potential - Fierce Pharma
-
Randomized Study Comparing a Novel Intranasal Formulation of Bumetanide With Oral and Intravenous Formulations - American Heart Association Journals
-
Lupin Receives Approval from U.S. FDA for Bumetanide Injection, USP - lupin.com
-
FDA Approves First Intranasal Diuretic, Enbumyst - Managed Healthcare Executive
-
Bumetanide Nasal Spray and the Future of Edema With Josephine Harrington, MD, and Nihar Desai, MD - HCPLive
-
Esperion Therapeutics and Corstasis Therapeutics Announce Esperion’s Definitive Agreement to Acquire Corstasis, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray) - Business Wire
-
Corstasis Therapeutics and Cardiovascular Logistics Partner to Redefine Outpatient Heart Failure Care with ENBUMYST™ (Bumetanide Nasal Spray) - Business Wire
-
Corstasis Therapeutics and U.S. Heart and Vascular® Collaboration Will Seek to Improve Heart Failure Care with ENBUMYST™ (Bumetanide Nasal Spray) - Business Wire
-
Lupin Launches Bumetanide Injection, USP in the United States - lupin.com
-
US Heart & Vascular, FillPoint Health, and Corstasis Therapeutics Announce Strategic Collaboration to Improve Heart Failure Care Through Enhanced Access to Enbumyst™ (bumetanide nasal spray) - Business Wire
-
Aptar Pharma device cleared for use with first intranasal loop diuretic - Medical Economics
-
First FDA-approved nasal spray diuretic joins Esperion portfolio - Stock Titan
-
Aptar Pharma’s Unidose System Delivers Enbumyst™, First U.S. FDA-Approved Intranasal Diuretic - Aptar
-
FDA Approves Bumetanide Nasal Spray for Edema in Heart, Liver, and Kidney Disease - Medical Dialogues
-
Experimental and real-world evidence supporting the computational repurposing of bumetanide for APOE4 -related Alzheimer’s disease - Nature
-
FDA Approves Cortasis Nasal Spray, Enbumyst, for Edema - PharmTech.com
-
Nasal Bumetanide Safe, Effective in Healthy Adults - TCTMD.com
-
RSQ-777-02: New Nasal Spray Form of Bumetanide as Effective as Oral and IV Forms in Patients Without HF or HF Risk - American College of Cardiology
-
7 Bumex (Bumetanide) Side Effects You Should Know About - GoodRx
-
FDA Accepts New Drug Application for Bumetanide Nasal Spray - HCPLive
-
The immuno-behavioural covariation associated with the treatment response to bumetanide in young children with autism spectrum disorder - Nature
-
Structural basis for inhibition of the Cation-chloride cotransporter NKCC1 by the diuretic drug bumetanide - Nature
-
Common drug may have potential for treating Alzheimer's disease - National Institutes of Health (.gov)
-
Corstasis Therapeutics Announces Allowance of a New Patent and Development Updates for Subcutaneous Programs RSQ-786 and RSQ-789 - Business Wire
-
Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodium-potassium-chloride-cotransporter human variants hNKCC1A and hNKCC1B - Nature
-
On Bumetanide? NHS Says Avoid Taking It After This Time Of Day - Health and Me
-
Bumetanide for autism: more eye contact, less amygdala activation - Nature
-
Heterogeneous brain distribution of bumetanide following systemic administration in rats - Wiley Online Library
-
Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders - Nature
-
Early bumetanide restores social communication in fragile X, autism model - UT Health San Antonio
-
Bumetanide Exposure Association with Alzheimer’s Disease Risk - Wiley
-
Bumetanide 1mg tablets shortage, NHS issues safety alert - Pharmacy Business
-
Going on Trial: Orphan drugs; CBD; bumetanide - The Transmitter
-
Bumetanide attenuates acute lung injury by suppressing macrophage activation - ScienceDirect.com
-
Bumetanide Nasal Spray Equivalent to Oral, IV Forms for Heart Failure - HCPLive
-
Corstasis Therapeutics Inc. Announces FDA Acceptance of New Drug Application for Bumetanide Nasal Spray - Business Wire
-
Novel Intranasal Loop Diuretic: - JACC Journals
-
Bumetanide treatment during early development rescues maternal separation-induced susceptibility to stress - Nature
-
Old Drug May Offer New Tricks for Alzheimer’s Disease - Fisher Center for Alzheimer's Research Foundation
-
Nasal spray form of bumetanide may be just as good as oral, IV - Healio
-
Bumetanide diuretic found to ease Angelman symptoms in mice - Angelman Syndrome News
-
NKCC1 Inhibitor Bumetanide Shows No Effect on Parkinson Disease Progression - Neurology Live
-
Bumetanide reminder as NHS says don't take it after certain time - Daily Express
-
Bumetanide increases postsynaptic inhibition after chronic SCI and decreases presynaptic inhibition with step-training - Wiley
-
Repurposing bumetanide for Alzheimer’s - Cure Parkinson's
-
Hydrolytic biotransformation of the bumetanide ester prodrug DIMAEB to bumetanide by esterases in neonatal human and rat serum and neonatal rat brain—A new treatment strategy for neonatal seizures? - Wiley Online Library
-
Breakthrough study reveals bumetanide treatment restores early social communication in fragile X syndrome mouse model - EurekAlert!
-
Patient safety alert issued over loop diuretic tablet shortage - thepharmacist.co.uk
-
New nasal spray form of bumetanide shows promise for heart failure treatment - News-Medical
-
The Loop Diuretic Bumetanide Blocks Posttraumatic p75NTR Upregulation and Rescues Injured Neurons - Journal of Neuroscience
-
Precision medicine data dive shows water pill may be viable to test as Alzheimer’s treatment - National Institute on Aging (.gov)
-
Corstasis Therapeutics to Present Pivotal Trial Data on Novel Bumetanide Nasal Spray at American Heart Association Scientific Sessions 2024 - BioSpace
-
Bumetanide may benefit only a subset of autistic children - The Transmitter
-
NIH Believes Common Diuretic Drug Bumetanide Could Lower Risk of Alzheimer’s - BioSpace
-
Bumetanide Prevents Brain Trauma-Induced Depressive-Like Behavior - Frontiers
-
Upsher-Smith Receives FDA Approval For Bumetanide Tablets, USP - PR Newswire
-
Chloride cotransporter NKCC1 inhibitor bumetanide protects against white matter injury in a rodent model of periventricular leukomalacia - Nature
-
Nasal Spray Diuretic Shows Potential for Heart Failure in Trial of Healthy Adults - MedPage Today
-
French pharma firms terminate trials of bumetanide for autism - The Transmitter
-
A randomised controlled trial of bumetanide in the treatment of autism in children - Nature
-
Nasal Spray Diuretic Evades Heart Failure Drug Flaw - Medscape
-
AHA: Bumetanide Nasal Spray Statistically Bioequivalent to Oral Bumetanide - HealthDay
-
Med Check: Allergan's Migraine Treatment, GI Warning for Clozapine, Alkermes' Treatment, Reyvow, Bumetanide - Psychiatry Online
-
Neonatal seizures: A promising new drug - Boston Children's Answers
-
Common Diuretic May Ease Autism Symptoms - MedPage Today
-
“Treating Autism with Bumetanide” - New book co-authored by GNCs Nouchine Hadjikhani - - Göteborgs universitet
-
Building a better drug - The Transmitter
-
A novel prodrug‐based strategy to increase effects of bumetanide in epilepsy - Töllner - 2014 - Annals of Neurology - Wiley Online Library
-
Autism drug fails in late-stage trials, Servier says - BioPharma Dive
-
Studies Suggest Oral Diuretic Pill Could Help Prevent Alzheimer's Disease in People at Genetic Risk - Genetic Engineering and Biotechnology News
-
Bumetanide - Farley - 2011 - Practical Diabetes - Wiley Online Library
-
Phase 3 Study Launched to Investigate Bumetanide to Treat Autism - drugdiscoverytrends.com
-
Cheap diuretic pill could help with autism symptoms - The Conversation
-
The bumetanide prodrug BUM5, but not bumetanide, potentiates the antiseizure effect of phenobarbital in adult epileptic mice - Wiley Online Library
-
Glenmark Pharma Unveils Generic Drug Bumetanide - BW Healthcare World
-
Lupin gets US FDA nod for Bumetanide Injection, USP - Express Pharma
-
FDA Approves Generic Bumex Tablets - Medical Professionals Reference
-
Lupin launches Bumetanide injection USP in the United States - Express Pharma
-
A Cheap Medication Could Help The Social Symptoms in Children With Autism - ScienceAlert
-
Lupin Launches Bumetanide Injection in the U.S. - ET Pharma
-
New preclinical data on NKCC1 inhibitor IAMA-6 in neurological disorder models - BioWorld News
-
A diuretic shows potential as an Alzheimer’s treatment - BioWorld News
-
Common Oral Diuretic Pill as Alzheimer’s Treatment, Study Shows - Drug Topics
-
Study Shows 'Water Pill' May Help Reduce Some Autism Symptoms In Young Kids - CBS News
-
Glenmark Pharmaceuticals launches generic version of diuretic Bumetanide injection - The Times of India
-
Lupin bags USFDA nod for Bumetanide Injection for edema treatment - Medical Dialogues
-
Repurposed drug boosts the positive effect of microglia to improve cognitive performance following brain trauma - Helsinki.fi
-
Parents giving unproven IQ-boosting drugs to kids with Down's - New Scientist
-
Lupin receives nod for generic Adderall XR, launches generic Bumex - Drug Store News
-
‘Water pill’ that’s used to reduce swelling hailed ‘real breakthrough for kids with autism’ | - The Sun
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.